Pharmaceutical compound
Clinical data | |
---|---|
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C16H14N2O2 |
Molar mass | 266.300 g·mol |
3D model (JSmol) | |
SMILES
| |
InChI
| |
(what is this?) (verify) |
Doliracetam is a nootropic drug (cognition enhancer) from the racetam family used in treatment of epilepsy.
According to the Hoechst patent title, it has neuroanabolic action.
See also
References
- EP 62887, Kuch, Heinz & Kruse, Hansjörg, "Indolinone-2 derivatives, process for their preparation and neuro-anabolic mediums containing them", published 1982-10-20, assigned to Hoechst AG
- Fariello RG, Ghelardini C, Di Cesare Mannelli L, Bonanno G, Pittaluga A, Milanese M, Misiano P, Farina C (June 2014). "Broad spectrum and prolonged efficacy of dimiracetam in models of neuropathic pain". Neuropharmacology. 81: 85–94. doi:10.1016/j.neuropharm.2014.01.029. PMID 24486381. S2CID 28039482.
Racetams | |
---|---|
Racetams |
|
Phenylpiracetams |
|
Racetam-like |
|
This drug article relating to the nervous system is a stub. You can help Misplaced Pages by expanding it. |